Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions - Wikidata - wikimedia - TriplyDB

Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions

Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions

http://www.wikidata.org/entity/Q34289043

about

IL-6 promotes cardiac graft rejection mediated by CD4+ cells.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

P2860

Q35566506-0E3AAC7C-2E89-4E53-93FB-4FC8289C4383 Q41849097-D9A43A99-B65B-444D-9623-2ADB7AA7E07C

P2860

Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions

http://www.wikidata.org/entity/Q34289043

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Immunological challenges of ca ...... wer current clinical questions

@ast

Immunological challenges of ca ...... wer current clinical questions

@en

Immunological challenges of ca ...... wer current clinical questions

@nl

type

label

Immunological challenges of ca ...... wer current clinical questions

@ast

Immunological challenges of ca ...... wer current clinical questions

@en

Immunological challenges of ca ...... wer current clinical questions

@nl

prefLabel

Immunological challenges of ca ...... wer current clinical questions

@ast

Immunological challenges of ca ...... wer current clinical questions

@en

Immunological challenges of ca ...... wer current clinical questions

@nl

P1433

Q34289043-C1EAE888-FC56-4C4C-891F-77632837D582

P1476

Q34289043-A53AEC60-7149-4082-89D8-53E07E837630

P2093

Q34289043-65C0D4D8-726C-4C95-9A74-7FF5BEE8369B

Q34289043-755CB6CF-9241-424A-B27A-4E673E10D642

Q34289043-77183A57-F75B-4B35-BFD2-767E391AC59C

Q34289043-99326561-2A74-40DB-8C21-CE1A54A72D4B

Q34289043-F9895357-0F9C-4642-983D-93C32F44A6E0

P2860

Q34289043-14581377-5D21-4A92-9FC3-12AF01107A04

Q34289043-1828F65A-F9B6-47BB-BC9D-CDDFB96EB3E9

Q34289043-18968D04-20D3-4E12-A19A-84D5E325B63B

Q34289043-2E6351C6-FD8C-4D5D-ACB3-D6D664AB8746

Q34289043-2F45E36C-67A0-4E1A-9FE4-6AF07DF353A6

Q34289043-335FD686-0BC0-42FE-9D84-62D0574B7975

Q34289043-3845BADE-9017-46FB-AA64-4A554FEC4FE7

Q34289043-3E6DC6B2-20ED-4484-8ACC-59721F4B841D

Q34289043-475DF9E8-9BAD-4DB1-A68B-B7D181D3E6BE

Q34289043-4E73CE18-5CD9-4800-AA81-CD3204F576B5

P2888

Q34289043-33567218-B464-4A15-80EF-A5DA253071FA

P304

Q34289043-EB2F9361-BF5F-4966-9CA5-73674FB74669

P31

Q34289043-7F70FB7D-FCE0-47AA-823D-71A6E6A2B86B

P356

Q34289043-962FD47C-2426-4C10-899E-297BE54BFDB6

P433

Q34289043-FE0B69C6-4559-477C-B867-1A21336CCCCE

P478

Q34289043-BD3E8FB6-8789-45C9-9307-184EFC7E421A

P577

Q34289043-1B061B8D-EC7E-4513-841E-62567C0E47F0

P5875

Q34289043-EA2C1494-EE67-4247-B882-9C1F5B966ED6

P6179

Q34289043-ACD912C5-8E35-4417-889A-2B8D1E1310B9

P698

Q34289043-2A7FD292-F231-4EFC-B3D8-0B1277414469

P921

Q34289043-45425DC1-E851-4E63-991C-AACA29AE8B0B

P932

Q34289043-D0716AFB-7A68-4CCF-8811-FF743A1DBB7F

P356

S10875-009-9334-4

P1433

Journal of Clinical Immunology

P1476

Immunological challenges of ca ...... wer current clinical questions

@en

P2093

Craig N Morrell

http://www.w3.org/2001/XMLSchema#string

E Rene Rodriguez

http://www.w3.org/2001/XMLSchema#string

Jennifer R Wehner

http://www.w3.org/2001/XMLSchema#string

Robert L Fairchild

http://www.w3.org/2001/XMLSchema#string

William M Baldwin

http://www.w3.org/2001/XMLSchema#string

P2860

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis

Actively acquired tolerance of foreign cells.

Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment.

Antibody to human leukocyte antigen triggers endothelial exocytosis.

Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection.

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

P2888

s10875-009-9334-4

P304

722-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-009-9334-4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26868930

http://www.w3.org/2001/XMLSchema#string

P6179

1006024326

http://www.w3.org/2001/XMLSchema#string

P698

19802689

http://www.w3.org/2001/XMLSchema#string

P921

P932

2975936

http://www.w3.org/2001/XMLSchema#string